These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk of kidney stones. Ettinger B JAMA; 1982 Oct; 248(16):1971. PubMed ID: 7120618 [No Abstract] [Full Text] [Related]
23. The true composition of kidney stones passed during triamterene therapy. Sörgel F; Ettinger B; Benet LZ J Urol; 1985 Nov; 134(5):871-3. PubMed ID: 4057369 [TBL] [Abstract][Full Text] [Related]
24. Excretion of triamterene and its metabolite in triamterene stone patients. Ettinger B J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113 [TBL] [Abstract][Full Text] [Related]
25. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites. Werness PG; Bergert JH; Smith LH J Lab Clin Med; 1982 Feb; 99(2):254-62. PubMed ID: 7061920 [TBL] [Abstract][Full Text] [Related]
33. Drug-induced renal stones: incidence, clinical expression and stone analysis. Rapado A; Traba ML; Caycho C; Cifuentes-Delatte L Contrib Nephrol; 1987; 58():25-9. PubMed ID: 2826078 [No Abstract] [Full Text] [Related]
34. Report of a death following administration of triamterene. Eitzen AC J Kans Med Soc; 1966 Sep; 67(9):454-5. PubMed ID: 5976595 [No Abstract] [Full Text] [Related]
35. Fever secondary to triamterene therapy. Safdi MA N Engl J Med; 1980 Sep; 303(12):701. PubMed ID: 7402257 [No Abstract] [Full Text] [Related]
37. Acute renal failure and hyperkalemia associated with triamterene and indomethacin. Mathews A; Bailie GR Vet Hum Toxicol; 1986 Jun; 28(3):224-5. PubMed ID: 3727353 [No Abstract] [Full Text] [Related]
38. [Detection and diagnosis of drug induced lithiasis]. Daudon M; Protat MF; Réveillaud RJ Ann Biol Clin (Paris); 1983; 41(4):239-49. PubMed ID: 6139048 [TBL] [Abstract][Full Text] [Related]
39. [Experimental oxalic lithiasis induced by hydroxyproline]. Thomas J; Thomas E; Balan L; Guillon JC; Melon JM; Monsaingeon A C R Seances Soc Biol Fil; 1971; 165(2):264-7. PubMed ID: 4258398 [No Abstract] [Full Text] [Related]
40. [Hypotensive effects of fursemide, triamterene and reserpine combination in patients with essential hypertension on ambulatory care]. Saldanha RV; Veras RO; de Paula e Silva P; de Serro-Azul LG Rev Paul Med; 1971 Nov; 78(4):137-40. PubMed ID: 5164638 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]